Cyclerion Therapeutics, Inc

(NASDAQ:CYCN)

Latest On Cyclerion Therapeutics, Inc (CYCN):

Date/Time Type Description Signal Details
2023-05-15 22:52 ESTNewsCyclerion announces 1 for 20 reverse stock splitN/A
2023-05-12 08:19 ESTNewsCyclerion Therapeutics down 6% on spin off agreementN/A
2023-03-27 13:59 ESTNewsCyclerion's zagociguat gets FDA orphan drug statusN/A
2022-11-22 18:57 ESTNewsCyclerion stock surges 16% on rejecting offer from CEO led group to buy assetsN/A
2022-10-06 10:24 ESTNewsCyclerion stock tanks 32% on workforce reduction, clinical development refocusN/A
2022-06-17 11:16 ESTNewsCyclerion Therapeutics rises 12% on positive data from mouse study to treat mitochondrial diseaseN/A
2022-06-10 18:36 ESTNewsCyclerion posts topline data for mitochondrial disease candidateN/A
2022-05-05 02:09 ESTNewsCyclerion Therapeutics reports Q1 resultsN/A
2022-01-26 20:23 ESTNewsCyclerion begins dosing in phase 2a trial of CY6463 for Alzheimer’s diseaseN/A
2021-11-10 06:11 ESTNewsCyclerion Therapeutics EPS beats by $0.09, misses on revenueN/A
2021-10-26 16:47 ESTNewsCyclerion Therapeutics: Distressed Spinoff Developing New Medicines For CNS DisordersN/A
2021-10-22 05:35 ESTNewsWarning: CYCN is at high risk of performing badlyN/A
2021-09-23 01:07 ESTNewsCyclerion shares rise 7% on the potential of its sGC stimulator CY6463N/A
2021-07-23 17:27 ESTNewsCyclerion gains after announcing upcoming presentation of Alzheimer’s study designN/A
2021-07-21 04:27 ESTNewsCyclerion inks global licensing agreement with Akebia for as much as $585MN/A
2021-07-21 04:24 ESTNewsCyclerion climbs on a series of insider purchasesN/A
2021-07-21 04:09 ESTNewsCyclerion Therapeutics: Insiders Buying With No Clinical Data Due Until YE 2021N/A
2021-07-21 03:47 ESTNewsCyclerion Therapeutics and Beacon Biosignals ink expanded strategic partnershipN/A
2021-04-28 12:47 ESTNewsCyclerion updates on clinical trial progress at webinarN/A
2021-03-18 17:20 ESTNewsCyclerion Therapeutics chief medical officer leavesN/A
2021-02-26 15:25 ESTEarnings EstimateAn EPS average of -$1.00 is estimated for the 2022 year.Sell
2021-02-26 15:25 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 23:27 ESTNewsCyclerion Therapeutics reports FY resultsN/A
2021-01-13 12:29 ESTNewsCyclerion Therapeutics +10% after prelim reportsN/A
2020-12-22 01:24 ESTNewsCyclerion Therapeutics announces promotionsN/A
2020-12-13 03:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 07:32 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:34 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 06:13 ESTNewsCyclerion Therapeutics reports Q3 resultsN/A
2020-10-15 14:45 ESTNewsCyclerion shows encouraging action in early-stage study in elderly volunteersN/A
2020-10-15 14:45 ESTNewsCyclerion's olinciguat data in sickle cell did not support clinical developmentN/A
2020-10-15 08:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $5 to $4.Neutral
2020-10-14 10:51 ESTNewsCyclerion shows encouraging action in early-stage studyN/A
2020-10-13 06:10 ESTNewsCyclerion Is A Speculative Biotech With A Few Catalysts ApproachingN/A
2020-09-26 12:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:39 ESTFinancialsCompany financials have been released.Neutral
2020-09-03 19:15 ESTNewsCyclerion Therapeutics inks $50M stock sales deal with JefferiesN/A
2020-08-14 08:32 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 16:33 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 10:59 ESTNewsCyclerion Therapeutics reports Q2 resultsN/A
2020-07-31 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-26 00:19 ESTNewsCyclerion files for $150M mixed shelfN/A
2020-07-23 16:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 08:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 08:31 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 16:40 ESTEarnings EstimateAn EPS average of -$0.82 is estimated for the quarter ending on September 30, 2020.Sell
2020-05-27 04:33 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 04:34 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:37 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 12:34 ESTFinancialsCompany financials have been released.Neutral

About Cyclerion Therapeutics, Inc (CYCN):

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase II trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Alzheimer's disease with vascular pathology (ADv); Olinciguat, an orally administered vascular soluble guanylate cyclase stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

CYCN Quotes by TradingView

See Advanced Chart

General

  • Name Cyclerion Therapeutics, Inc
  • Symbol CYCN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 34
  • Fiscal Year EndDecember
  • IPO Date2019-04-02
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.cyclerion.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 58.53
  • Price/Book (Most Recent Quarter) 2.53
  • Enterprise Value Revenue 61.79
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.31
  • Next Year EPS Estimate -$1.00
  • Operating Margin -3420%
  • Return on Assets -33%
  • Return on Equity -99%
  • Revenue 2.3 million
  • Earnings Per Share -$4.74
  • Revenue Per Share $0.08
  • Gross Profit 2.3 million
  • Quarterly Earnings Growth -91%
View More

Highlights

  • Market Capitalization 143.37 million
  • EBITDA -118158000
  • PE Ratio -0.77
  • Analyst Target Price $4
  • Book Value Per Share $1.75
View More

Share Statistics

  • Shares Outstanding 33.96 million
  • Shares Float 22.68 million
  • % Held by Insiders 1505%
  • % Held by Institutions 72.16%
  • Shares Short 545983
  • Shares Short Prior Month 688746
  • Short Ratio 0.38
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $8.96
  • 52 Week Low $2.18
  • 50 Day Moving Average 4.11
  • 200 Day Moving Average 4.16
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Cyclerion Therapeutics, Inc (CYCN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cyclerion Therapeutics, Inc (CYCN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$133000-$0.55-$0.19-189.47%
2020-09-302020-11-05$N/A-$0.59-$0.56-5.36%
2020-06-302020-08-03$N/A-$0.70-$0.8618.89%
2020-03-312020-05-04$N/A-$0.73-$0.8716.09%
2019-12-312020-03-12$1.48 million-$0.95-$0.89-6.5%
2019-09-302019-11-12$1.4 million-$1.00-$1.3023.02%
2019-06-302019-08-12$1.63 million-$1.18-$0.84-41.15%
2019-03-312019-04-23$N/A-$1.36

Cyclerion Therapeutics, Inc (CYCN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Cyclerion Therapeutics, Inc (CYCN) Chart:

Cyclerion Therapeutics, Inc (CYCN) News:

Below you will find a list of latest news for Cyclerion Therapeutics, Inc (CYCN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cyclerion Therapeutics, Inc (CYCN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest CYCN Trades:

Date Shares Price
Jun 13, 2022 2:28 PM EST900$0.5111
Jun 13, 2022 5:35 PM EST100$0.5099
Jun 13, 2022 6:20 PM EST200$0.57
Jun 13, 2022 7:28 PM EST1000$0.54
Jun 13, 2022 7:28 PM EST550$0.54

Cyclerion Therapeutics, Inc (CYCN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920074702/0001104659-20-074702-index.htm
2018-11-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1755237/000000000018034596/0000000000-18-034596-index.htm
2018-12-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1755237/000000000018038336/0000000000-18-038336-index.htm
2019-03-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1755237/000000000019004815/0000000000-19-004815-index.htm
2019-04-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1755237/000000000019007200/0000000000-19-007200-index.htm
2020-07-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1755237/000000000020006988/0000000000-20-006988-index.htm
2020-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1755237/000000000020007365/0000000000-20-007365-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000031506620000899/0000315066-20-000899-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000083423720008046/0000834237-20-008046-index.htm
2020-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000083423720010209/0000834237-20-010209-index.htm
2020-08-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000090266420002944/0000902664-20-002944-index.htm
2020-08-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000090266420002945/0000902664-20-002945-index.htm
2019-04-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000090445419000355/0000904454-19-000355-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000090445420000173/0000904454-20-000173-index.htm
2018-10-09DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000091205718000392/0000912057-18-000392-index.htm
2018-12-06DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000091205718000507/0000912057-18-000507-index.htm
2019-01-07DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000091205719000008/0000912057-19-000008-index.htm
2019-04-09DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000091205719000160/0000912057-19-000160-index.htm
2019-12-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000093583619000672/0000935836-19-000672-index.htm
2019-01-2810-12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1755237/000104746919000256/0001047469-19-000256-index.htm
2019-03-0410-12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1755237/000104746919000876/0001047469-19-000876-index.htm
2019-03-1110-12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1755237/000104746919001059/0001047469-19-001059-index.htm
2019-04-18S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1755237/000104746919002389/0001047469-19-002389-index.htm
2019-04-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1755237/000104746919002505/0001047469-19-002505-index.htm
2019-03-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1755237/000110465919014230/0001104659-19-014230-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919014911/0001104659-19-014911-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919014913/0001104659-19-014913-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919014914/0001104659-19-014914-index.htm
2019-03-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919014989/0001104659-19-014989-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919016052/0001104659-19-016052-index.htm
2019-03-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919018720/0001104659-19-018720-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919019416/0001104659-19-019416-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919019466/0001104659-19-019466-index.htm
2019-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919020379/0001104659-19-020379-index.htm
2019-04-17DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465919021921/0001104659-19-021921-index.htm
2019-04-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1755237/000110465919022786/0001104659-19-022786-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919028766/0001104659-19-028766-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1755237/000110465919028981/0001104659-19-028981-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919045189/0001104659-19-045189-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1755237/000110465919045323/0001104659-19-045323-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919051352/0001104659-19-051352-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465919057505/0001104659-19-057505-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1755237/000110465919062590/0001104659-19-062590-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920003162/0001104659-20-003162-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920029761/0001104659-20-029761-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1755237/000110465920032554/0001104659-20-032554-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920046446/0001104659-20-046446-index.htm
2020-05-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1755237/000110465920056280/0001104659-20-056280-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920074702/0001104659-20-074702-index.htm
2020-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920082390/0001104659-20-082390-index.htm
2020-07-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1755237/000110465920086517/0001104659-20-086517-index.htm
2020-07-30S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1755237/000110465920088412/0001104659-20-088412-index.htm
2020-07-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1755237/000110465920088538/0001104659-20-088538-index.htm
2020-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1755237/000110465920089193/0001104659-20-089193-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920089685/0001104659-20-089685-index.htm
2020-08-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1755237/000110465920091997/0001104659-20-091997-index.htm
2020-08-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000110465920093290/0001104659-20-093290-index.htm
2020-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1755237/000110465920093961/0001104659-20-093961-index.htm
2020-08-17424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1755237/000110465920095986/0001104659-20-095986-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920102011/0001104659-20-102011-index.htm
2020-09-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1755237/000110465920102276/0001104659-20-102276-index.htm
2020-09-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1755237/000110465920107118/0001104659-20-107118-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920110691/0001104659-20-110691-index.htm
2020-10-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1755237/000110465920114699/0001104659-20-114699-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1755237/000114036120009594/0001140361-20-009594-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1755237/000114036120009597/0001140361-20-009597-index.htm
2020-02-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000119312520023050/0001193125-20-023050-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000119312520038302/0001193125-20-038302-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023363/0001209191-19-023363-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023381/0001209191-19-023381-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023460/0001209191-19-023460-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023461/0001209191-19-023461-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023485/0001209191-19-023485-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023486/0001209191-19-023486-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023487/0001209191-19-023487-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023488/0001209191-19-023488-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023489/0001209191-19-023489-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023494/0001209191-19-023494-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023507/0001209191-19-023507-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023509/0001209191-19-023509-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023514/0001209191-19-023514-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023517/0001209191-19-023517-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023519/0001209191-19-023519-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023521/0001209191-19-023521-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023522/0001209191-19-023522-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023554/0001209191-19-023554-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023556/0001209191-19-023556-index.htm
2019-04-034/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023565/0001209191-19-023565-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023566/0001209191-19-023566-index.htm
2019-04-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119023727/0001209191-19-023727-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119024236/0001209191-19-024236-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119024237/0001209191-19-024237-index.htm
2019-05-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119026819/0001209191-19-026819-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119026820/0001209191-19-026820-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034369/0001209191-19-034369-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034371/0001209191-19-034371-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034373/0001209191-19-034373-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034375/0001209191-19-034375-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034376/0001209191-19-034376-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034379/0001209191-19-034379-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034382/0001209191-19-034382-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119034383/0001209191-19-034383-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119041920/0001209191-19-041920-index.htm
2019-09-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119050308/0001209191-19-050308-index.htm
2019-09-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119050309/0001209191-19-050309-index.htm
2019-09-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119050311/0001209191-19-050311-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119056008/0001209191-19-056008-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119057112/0001209191-19-057112-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119058158/0001209191-19-058158-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119058162/0001209191-19-058162-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119058163/0001209191-19-058163-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119058165/0001209191-19-058165-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919119062322/0001209191-19-062322-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120012430/0001209191-20-012430-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120022657/0001209191-20-022657-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037566/0001209191-20-037566-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037568/0001209191-20-037568-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037571/0001209191-20-037571-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037573/0001209191-20-037573-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037575/0001209191-20-037575-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037580/0001209191-20-037580-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037587/0001209191-20-037587-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120037589/0001209191-20-037589-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1755237/000120919120057302/0001209191-20-057302-index.htm
2019-03-14CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1755237/000135445719000129/0001354457-19-000129-index.htm
2018-10-09DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000141057818000440/0001410578-18-000440-index.htm
2018-12-06DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000141057818000589/0001410578-18-000589-index.htm
2019-01-07DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1755237/000141057819000010/0001410578-19-000010-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1755237/000156459020050844/0001564590-20-050844-index.htm
2019-06-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000165495419007382/0001654954-19-007382-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1755237/000165495420001573/0001654954-20-001573-index.htm
2019-04-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1755237/999999999519000803/9999999995-19-000803-index.htm
2020-07-31EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1755237/999999999520001998/9999999995-20-001998-index.htm
2020-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1755237/999999999520002162/9999999995-20-002162-index.htm
2019-03-14SEC STAFF SEC Staff Action: ORDERhttps://www.sec.gov/Archives/edgar/data/1755237/999999999719001156/9999999997-19-001156-index.htm

Cyclerion Therapeutics, Inc (CYCN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cyclerion Therapeutics, Inc (CYCN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1505%
Institutional Ownership: 7216%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-11-15Andreas BuschChief Innovation OfficerBuy125,000.001.82227,500.00125,000.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119057112/0001209191-19-057112-index.htm
2019-04-01Marsha FanucciDirectorBuy13,671.0013,671.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023507/0001209191-19-023507-index.htm
2019-03-29IRONWOOD PHARMACEUTICALS INC10% Share HolderBuy15,562,455.0015,562,555.00https://www.sec.gov/Archives/edgar/data/1755237/000110465919019466/0001104659-19-019466-index.htm
2019-04-01TERRANCE MCGUIREDirectorBuy162.00162.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023566/0001209191-19-023566-index.htm
2019-04-01Marsha FanucciDirectorBuy3,279.0016,950.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023507/0001209191-19-023507-index.htm
2019-04-08AMY W SCHULMANDirectorBuy21,635.0016.00346,160.0021,635.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119024236/0001209191-19-024236-index.htm
2019-04-08TERRANCE MCGUIREDirectorBuy21,635.0016.00346,160.0021,635.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119024237/0001209191-19-024237-index.htm
2019-04-01Peter M HechtChief Executive OfficerBuy223,192.00223,192.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023556/0001209191-19-023556-index.htm
2019-07-10Peter M HechtChief Executive OfficerBuy2,000.006.0412,080.00225,192.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119041920/0001209191-19-041920-index.htm
2019-04-01GEORGE H CONRADESDirectorBuy2,421.002,421.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023461/0001209191-19-023461-index.htm
2019-04-01Kevin ChurchwellDirectorBuy2,421.002,421.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023381/0001209191-19-023381-index.htm
2019-04-01Michael MendelsohnDirectorBuy2,421.002,421.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023494/0001209191-19-023494-index.htm
2019-04-01Ole IsacsonDirectorBuy2,421.002,421.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023486/0001209191-19-023486-index.htm
2019-04-01Stephanie LovellDirectorBuy2,421.002,421.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023488/0001209191-19-023488-index.htm
2019-12-30Mark G CurriePresidentSell25,000.002.4862,000.00271,755.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119062322/0001209191-19-062322-index.htm
2019-12-27Mark G CurriePresidentSell25,000.002.5563,750.00296,755.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119062322/0001209191-19-062322-index.htm
2019-04-02Mark G CurriePresidentBuy270,107.0014.814,000,284.67321,755.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023521/0001209191-19-023521-index.htm
2019-04-01TERRANCE MCGUIREDirectorBuy3,279.003,279.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023566/0001209191-19-023566-index.htm
2019-04-01William HuyettChief Financial OfficerBuy38,327.0038,327.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023517/0001209191-19-023517-index.htm
2019-04-01AMY W SCHULMANDirectorBuy4,229.004,229.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023514/0001209191-19-023514-index.htm
2019-04-01Peter M HechtChief Executive OfficerBuy485.00485.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023556/0001209191-19-023556-index.htm
2019-04-01Mark G CurriePresidentBuy51,648.0051,648.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023521/0001209191-19-023521-index.htm
2019-04-08AMY W SCHULMANDirectorBuy604,482.0016.009,671,712.00604,482.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119024236/0001209191-19-024236-index.htm
2019-04-08TERRANCE MCGUIREDirectorBuy604,482.0016.009,671,712.00604,482.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119024237/0001209191-19-024237-index.htm
2019-04-01TERRANCE MCGUIREDirectorBuy6,911.006,911.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023566/0001209191-19-023566-index.htm
2020-02-21William HuyettChief Financial OfficerSell3,559.005.1218,222.0871,417.00https://www.sec.gov/Archives/edgar/data/1755237/000120919120012430/0001209191-20-012430-index.htm
2019-11-08William HuyettChief Financial OfficerSell3,922.002.058,040.1074,976.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119056008/0001209191-19-056008-index.htm
2019-04-01AMY W SCHULMANDirectorBuy3,279.007,508.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023514/0001209191-19-023514-index.htm
2019-04-01TERRANCE MCGUIREDirectorBuy7,768.007,768.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023566/0001209191-19-023566-index.htm
2019-04-01William HuyettChief Financial OfficerBuy39,179.0078,912.00https://www.sec.gov/Archives/edgar/data/1755237/000120919119023517/0001209191-19-023517-index.htm